Annual General Meeting   Vitrolife AB (publ) 23 April 2004

Dividend
The AGM approved the proposal from the Board of Directors not to distribute a
dividend to shareholders for 2003.

The board of directors
The AGM appointed Madeleine Olsson-Eriksson as a new member and approved re-election of the board members Per Båtelson, Mark Dumenil, Claes Glassell, Lars Hamberger and Patrik Tigerschiöld. At a statutory Board meeting Patrik Tigerschiöld was elected as Chairman of the Board of Directors.

The Board of Directors
Vitrolife AB (publ), 23 April 2004

For further information, please contact;

 CEO: Dr. Magnus Nilsson 		
 Tel: +46 31 721 80 00 			
 Mobile +46 708 22 80 61		
 [email protected]			

Acting CFO and IR agent: Anders Sävfält
Tel: +46 31 721 80 00
[email protected]

_______________

Vitrolife is a global biomedical corporation that works with products for cell and tissue technology. The Vitrolife group consists of the parent company, Vitrolife AB (Publ) and two wholly owned subsidiaries: Vitrolife Sweden AB (Gothenburg, Sweden), Vitrolife Inc. (Denver, Colorado). The group's operations focused on three geographic areas.

· Europe/Middle East
· The Americas
· Rest of the World

Vitrolife's business concept is to develop, produce and sell advanced products and systems for the preparation, cultivation, preservation and support of cells, tissues and organs.

_______________